Obalon Therapeutics Inc.

NASDAQ: OBLN · Real-Time Price · USD
3.05
-0.19 (-5.86%)
At close: Jun 16, 2021, 6:00 AM

Obalon Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2021 Q1 2021
Period Ending Jun 30, 2021 Mar 31, 2021
Net Income
-7.06M -11.24M
Depreciation & Amortization
457K 784K
Stock-Based Compensation
64K 710K
Other Working Capital
-350K -1.94M
Other Non-Cash Items
-392.1K 2.16M
Deferred Income Tax
n/a n/a
Change in Working Capital
-67K -2.45M
Operating Cash Flow
-6.99M -10.04M
Capital Expenditures
-250K 155K
Cash Acquisitions
n/a n/a
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
5.21M n/a
Investing Cash Flow
4.96M 155K
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
36.29M 9.89M
Financial Cash Flow
36.29M 9.89M
Net Cash Flow
33.41M 57K
Free Cash Flow
-7.24M -9.88M